You searched for united kingdom - Page 34 of 55

News and Trends 12 May 2023

5 highlights at first Genomics and Precision Medicine Expo

Genomics and Precision Medicine Expo – taking place on May 23 and 24 2023 at ExCeL London – has announced its top 5 highlights for this year’s inaugural conference. The…

May 12, 2023 - 4 minutesmins - By Jim Cornall

zika mosquito oxitcec fda swarm florida trial genetic engineering infectious disease

News and Trends 14 Mar 2016

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes in the US – and stop the spread of Dengue and Zika. As a spin-off…

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

Acacia Pharma Phase III Post Operative Nausea

More News! 13 Feb 2017

To the Rescue: A Final Phase III Success for Post-Operative Nausea

The dopamine antagonist Baremsis is on its way to FDA approval for the treatment and prophylaxis of post-operative nausea & vomiting, after succeeding in a final phase III study. Acacia…

February 13, 2017 - 3 minutesmins - By Melanie De Almeida

genomics england illumina 100 project partner uk

News and Trends 12 Feb 2016

World’s Largest Genome Sequencing Project partners with Global Leader in NGS

Genomics England (UK) today announce a partnership with the Next-Generation Sequencing Giant, Illumina (US), to develop a platform that can be used to improve and automate genome interpretation as part…

February 12, 2016 - 2 minutesmins - By Dani Bancroft

Anastasiia Slynko biotech investment 744x368 1

In Depth 11 Oct 2022

The biggest private biotech investments in September 2022

October 12th 2022: Article updated to remove incorrect Pharnext funding round from the text. The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022, with…

October 11, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Sep 2017

Verona Achieves Successful Results for Phase IIa Trial of Deadly Lung Disease Drug

A study of Verona’s combination therapy for COPD observed a clinical improvement in lung function and faster onset-of-action. Verona filed for its US IPO and dosed the first patient in…

September 7, 2017 - 2 minutesmins - By Alex Dale

In Depth 25 Mar 2019

Where Does Brexit Leave European Biotech?

In the next couple of months, the UK will officially exit the EU, in a move that is popularly known as Brexit. With this date fast approaching, companies, organizations and…

March 25, 2019 - 9 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 1 Aug 2018

London Biotech Raises €47M to Develop First Treatment Against RSV Virus

ReViral will dedicate the funds to run two clinical trials to test whether its antiviral can help patients at high risk from RSV infections. The respiratory syncytial virus (RSV) only…

August 1, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

celixir rnai silencing cancer colon breast

News and Trends 14 May 2019

RNAi Therapy Smashes Solid Tumors in Preclinical Tests

Developed by the UK biotech Celixir, a therapy based on silencing genes with RNA molecules in a process called RNAi has shrunk tumors by 50% in culture. Although there are…

May 14, 2019 - 2 minutesmins - By Jonathan Smith

orangutan apes deforestation yeast bath biotech palm oil

News and Trends 4 Jan 2016

Biotech and €6M to Save Orangutans? How a Yeast Alternative to Palm Oil could Stop Deforestation

Armed with a €6M Industry Grant, the Universities of Bath and York in the UK are researching how Yeast could provide a Palm-Oil alternative and save our Great Apes from…

January 4, 2016 - 3 minutesmins - By Joachim Eeckhout

News and Trends 11 Mar 2017

You Can Watch Fleming’s Original Penicillin Culture in Oxford!

The Museum of the History of Science in Oxford is hosting an exhibition on the history of penicillin and the current challenges of antibiotic resistance featuring the first culture used…

March 11, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Circassia pharmaceuticals astrazeneca pulmonary disease

News and Trends 7 Sep 2017

Circassia Moves Away from a Failed Allergy Pipeline with Phase III Success

Circassia has positive Phase III results from its respiratory pipeline, great news for the company after abandoning its allergy immunotherapies due to clinical failure. Circassia Pharmaceuticals, based in Oxford, has…

September 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: united kingdom

5 highlights at first Genomics and Precision Medicine Expo

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

To the Rescue: A Final Phase III Success for Post-Operative Nausea

World’s Largest Genome Sequencing Project partners with Global Leader in NGS

The biggest private biotech investments in September 2022

Verona Achieves Successful Results for Phase IIa Trial of Deadly Lung Disease Drug

Where Does Brexit Leave European Biotech?

London Biotech Raises €47M to Develop First Treatment Against RSV Virus

RNAi Therapy Smashes Solid Tumors in Preclinical Tests

Biotech and €6M to Save Orangutans? How a Yeast Alternative to Palm Oil could Stop Deforestation

You Can Watch Fleming’s Original Penicillin Culture in Oxford!

Circassia Moves Away from a Failed Allergy Pipeline with Phase III Success

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!